2-85327297-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006464.4(TGOLN2):c.435G>T(p.Gln145His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000807 in 1,611,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006464.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGOLN2 | NM_006464.4 | c.435G>T | p.Gln145His | missense_variant | 2/4 | ENST00000377386.8 | NP_006455.2 | |
TGOLN2 | NM_001368095.1 | c.435G>T | p.Gln145His | missense_variant | 2/4 | NP_001355024.1 | ||
TGOLN2 | NM_001368096.1 | c.435G>T | p.Gln145His | missense_variant | 2/4 | NP_001355025.1 | ||
TGOLN2 | NM_001206844.2 | c.435G>T | p.Gln145His | missense_variant | 2/5 | NP_001193773.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGOLN2 | ENST00000377386.8 | c.435G>T | p.Gln145His | missense_variant | 2/4 | 1 | NM_006464.4 | ENSP00000366603 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152084Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000562 AC: 14AN: 249266Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135224
GnomAD4 exome AF: 0.00000823 AC: 12AN: 1458956Hom.: 0 Cov.: 37 AF XY: 0.00000827 AC XY: 6AN XY: 725756
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152084Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.435G>T (p.Q145H) alteration is located in exon 2 (coding exon 2) of the TGOLN2 gene. This alteration results from a G to T substitution at nucleotide position 435, causing the glutamine (Q) at amino acid position 145 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at